BNGO - Bionano Genomics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures4

Market Cap (intraday) 228.91M
Enterprise Value 127.40M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)8.08
Price/Book (mrq)0.95
Enterprise Value/Revenue 4.32
Enterprise Value/EBITDA -1.01

Trading Information

Stock Price History

Beta (5Y Monthly) 2.25
52-Week Change 3-50.93%
S&P500 52-Week Change 33.90%
52 Week High 34.3500
52 Week Low 30.6000
50-Day Moving Average 30.8252
200-Day Moving Average 31.6617

Share Statistics

Avg Vol (3 month) 37.89M
Avg Vol (10 day) 310.23M
Shares Outstanding 5306.79M
Implied Shares Outstanding 6N/A
Float 8305.06M
% Held by Insiders 11.82%
% Held by Institutions 127.93%
Shares Short (May 14, 2023) 464.4M
Short Ratio (May 14, 2023) 46.07
Short % of Float (May 14, 2023) 421.11%
Short % of Shares Outstanding (May 14, 2023) 420.99%
Shares Short (prior month Apr 13, 2023) 462.89M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Mar 30, 2023


Profit Margin 0.00%
Operating Margin (ttm)-465.71%

Management Effectiveness

Return on Assets (ttm)-26.84%
Return on Equity (ttm)-51.51%

Income Statement

Revenue (ttm)29.52M
Revenue Per Share (ttm)0.10
Quarterly Revenue Growth (yoy)30.20%
Gross Profit (ttm)5.95M
EBITDA -126.88M
Net Income Avi to Common (ttm)-139.77M
Diluted EPS (ttm)-0.5000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)95.81M
Total Cash Per Share (mrq)0.31
Total Debt (mrq)11.17M
Total Debt/Equity (mrq)4.83
Current Ratio (mrq)3.74
Book Value Per Share (mrq)0.75

Cash Flow Statement

Operating Cash Flow (ttm)-124.73M
Levered Free Cash Flow (ttm)-58.62M